AI Podcasts
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

AI Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
AIPodcasts375: How AI Is Changing Healthtech Investing, According to Define Ventures’ Lynne Chou O’Keefe
375: How AI Is Changing Healthtech Investing, According to Define Ventures’ Lynne Chou O’Keefe
AIVenture Capital

AI and the Future of Work

375: How AI Is Changing Healthtech Investing, According to Define Ventures’ Lynne Chou O’Keefe

AI and the Future of Work
•February 9, 2026•44 min
0
AI and the Future of Work•Feb 9, 2026

Why It Matters

Understanding AI’s evolving role is crucial for investors, founders, and clinicians aiming to build sustainable health‑tech solutions that improve outcomes and reduce costs. As healthcare moves toward prevention and patient‑centric models, aligning technology with ethical standards and human judgment will determine the sector’s future impact.

AI Summary

In this episode, Lynne Chou O’Keefe, founder and managing partner of Define Ventures, discusses how AI is reshaping health‑tech investing amid a fragmented healthcare system and the shift toward value‑based care. She outlines three phases of AI adoption—from streamlining administrative tasks, to supporting clinical workflows, and ultimately influencing decision‑making—while emphasizing that AI should augment, not replace, clinicians. The conversation also explores patient expectations for instant, seamless care and the ethical boundaries between AI‑assisted and AI‑led treatment, especially in underserved settings.

Episode Description

Send us a text

Lynne Chou O’Keefe is the Founder and Managing Partner of Define Ventures, one of the largest early-stage health tech investment firms, with $800 million in assets under management.

With deep experience across digital health, venture capital, and frontline healthcare systems, Lynne brings a clear-eyed view of why the industry is changing now and where AI can make a meaningful difference. 

She is widely recognized for her work backing companies that rethink access, outcomes, and patient experience, and is a trusted voice on how technology, ethics, and human judgment must come together to move healthcare forward.

In this conversation, we discuss:

Why healthcare still runs on fragmented systems and what that means for where AI can truly move the needle.

How the shift from fee-for-service to value-based care changes incentives and pushes the system toward prevention over volume.

Why patients now expect healthcare to work like transportation or food delivery, and how that expectation reshapes care delivery.

The three phases of AI in healthcare, from administrative efficiency to clinical workflow support and, eventually, clinical decision-making.

Where the ethical boundary sits today between AI-assisted care and AI-led decisions, especially when access to care is limited.

Why the future of healthcare is hybrid by design, with AI augmenting clinicians rather than replacing human judgment.

Resources:

Subscribe to the AI & The Future of Work Newsletter

Connect with Lynn on LinkedIn

AI fun fact article

On how AI is fixing the biggest problem faced by doctors.

Show Notes

0

Comments

Want to join the conversation?

Loading comments...